Figure 6. Effect of PEITC and cisplatin alone or in combination on MPM cells viability over time.

MPM cells treatment with cisplatin (0.8mg/l) and/or PEITC (6μM) were performed every three days to assess cell viability over 9 days. Viability was measured at day 3, 6 and 9 using Uptiblue cell counting reagent. Values represent the mean ± SEM of triplicates. * p<0.05, ** p<0.01, *** p<0.001.